Advertisement
Advertisement
ATOS
Atossa Therapeutics, Inc. Common Stock
2.29
USDSponsored
-0.12
-4.77%
Jul 24, 15:59 UTC -4
Closed
After-Market
2.29
0.00
0.00%
ATOS Earnings Reports
Positive Surprise Ratio
ATOS beat 21 of 33 last estimates.
64%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$1.04
Implied change from Q1 26 (Revenue/ EPS)
--
/-6.31%
Implied change from Q2 25 (Revenue/ EPS)
--
/-0.95%
Atossa Therapeutics, Inc. Common Stock earnings per share and revenue
On May 08, 2026, ATOS reported earnings of -1.11 USD per share (EPS) for Q1 26, beating the estimate of -6.24 USD, resulting in a 82.23% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.23% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -1.04 USD, with revenue projected to reach -- USD, implying an decrease of -6.31% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.53%
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.27%
AngioDynamics, Inc.
Report Date
Jul 14, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+23.75%
FAQ
What were Atossa Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Atossa Therapeutics, Inc. Common Stock reported EPS of -$1.11, beating estimates by 82.23%, and revenue of $0.00, 0% as expectations.
How did the market react to Atossa Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -1.23%, changed from $5.67 before the earnings release to $5.60 the day after.
When is Atossa Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Atossa Therapeutics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Atossa Therapeutics, Inc. Common Stock is expected to report EPS of -$1.04 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement